✦ LIBER ✦

Association of pre-intervention activated clotting times (ACT) and clinical outcomes following percutaneous coronary revascularization: Results from the IMPACT-II trial

✍ Scribed by Frank V. Aguirre; James J. Ferguson; James C. Blankenship; Karen S. Pieper; Marc Taylor; Robert A. Harrington; Michele Rund; Eugene A. Caracciolo; Thomas J. Donohue; Robert M. Califf; A.Michael Lincoff; James E. Tcheng; Eric J. Topol

Book ID: 118585031
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 177 KB
Volume: 27
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(96)80532-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of abciximab versus tirofiban on

Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes—observations from the TARGET trial

✍ Ivan P Casserly; Eric J Topol; Gang Jia; Richard A Lange; Christian Hamm; Bernha 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Impact of an Initial Strategy of Medical

Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial

✍ David J. Maron; John A. Spertus; G.B. John Mancini; Pamela M. Hartigan; Steven P 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 785 KB